News and Views

Evidence-Based Practice

Put Evidence Into Practice to Prevent Infection

Because of immunosuppression from cancer or its treatment, patients are at a higher risk for viral, bacterial, and fungal infections. Patients who develop infections may experience dose delays or reductions that compromise optimal treatment outcomes, resulting in higher mortality rates, longer hospitalizations, and higher cost of care.

Trending Topics

View All Topics

The Future Is Full of Opportunities for Advancing Oncology Nursing and Cancer Care

The Future Is Full of Opportunities for Advancing Oncology Nursing and Cancer Care

FDA Approves Rucaparib for Treatment of Recurrent Ovarian Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Rucaparib for Treatment of Recurrent Ovarian Cancer

APRNs Bridge the Gap in Survivorship Care

Advanced Practice Nursing (APRN)

APRNs Bridge the Gap in Survivorship Care

ONS Shares Chemotherapy Education in Sub-Saharan Africa

Nursing Education

ONS Shares Chemotherapy Education in Sub-Saharan Africa

ONS Board Looks In the Rearview Mirror as We Cruise Ahead

ONS Board of Directors

ONS Board Looks In the Rearview Mirror as We Cruise Ahead

Cancer and Immunotherapy Organizations Release Checkpoint Inhibitor Side Effect Guidelines

Cancer and Immunotherapy Organizations Release Checkpoint Inhibitor Side Effect Guidelines

Expressive Writing Can Help Patients Understand and Process Their Cancer Diagnosis

Patient Support

Expressive Writing Can Help Patients Understand and Process Their Cancer Diagnosis

Supportive Care Programs for Patients With Cancer

Patient Support

Supportive Care Programs for Patients With Cancer

FDA Grants Accelerated Approval to Blinatumomab for B-Cell Precursor ALL

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Blinatumomab for B-Cell Precursor ALL

Oncology Nurses Play Key Role in Genetics Education, Testing for Patients

Genetics & Genomics

Oncology Nurses Play Key Role in Genetics Education, Testing for Patients

Newly Approved Cancer Treatments Indicate Growing Role of Genomics and Oral Therapies

U.S. Food and Drug Administration (FDA)

Newly Approved Cancer Treatments Indicate Growing Role of Genomics and Oral Therapies

Prevent Colorectal Cancer Through Screening

Cancer Prevention

Prevent Colorectal Cancer Through Screening

Lay Patient Navigators Can Help Oncology Nurses Guide Patients Through Cancer Care

Nurse Navigator

Lay Patient Navigators Can Help Oncology Nurses Guide Patients Through Cancer Care

Managing Weight Loss in Patients With Cancer

Advanced Practice Nursing (APRN)

Managing Weight Loss in Patients With Cancer

Nurse Empowerment

ONS Membership Elects New Board of Directors

FDA Approves Nilotinib for Pediatric Patients With Chronic Phase Ph+ CML

U.S. Food and Drug Administration (FDA)

FDA Approves Nilotinib for Pediatric Patients With Chronic Phase Ph+ CML

Integrate Evidence With Clinical Expertise and Patient Preferences and Values

Evidence-Based Practice

Integrate Evidence With Clinical Expertise and Patient Preferences and Values

Two Bacteria Species Connected to Certain Colon Cancers

Two Bacteria Species Connected to Certain Colon Cancers

FDA Approves Brentuximab Vedotin for Previously Untreated Stage III, IV Classical Hodgkin Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Brentuximab Vedotin for Previously Untreated Stage III, IV Classical Hodgkin Lymphoma

Nurse Empowerment

ONS Develops Wallet Cards to Coordinate Care for Patients Receiving Immunotherapy

How ONS Supports Oncology Nurse Navigators in Care Coordination

Care Coordination

How ONS Supports Oncology Nurse Navigators in Care Coordination

The Case of the Pain Paradox: Follow-Up and Clinical Trial

Pain Management

The Case of the Pain Paradox: Follow-Up and Clinical Trial

ONS Members Help Define Checkpoint Inhibitor Adverse Event Guidelines

ONS Members Help Define Checkpoint Inhibitor Adverse Event Guidelines

Study Reports Overall U.S. Cancer Incidence Trends

Cancer Research

Study Reports Overall U.S. Cancer Incidence Trends

ONS Board Establishes Process for Officer Election, Begins Charter for Leadership Committee

ONS Board of Directors

ONS Board Establishes Process for Officer Election, Begins Charter for Leadership Committee

Massage Therapy Helps Manage Breast Cancer-Related Lymphedema

Massage Therapy Helps Manage Breast Cancer-Related Lymphedema

What Oncology Nurses Need to Know About Pharmacogenomics

Clinical Practice

What Oncology Nurses Need to Know About Pharmacogenomics

Nurse Empowerment

ONS Brings Together Health Policy Experts, Patient Advocates for April Policy Summit

U.S. Cancer Death Rates Continue to Fall

American Cancer Society (ACS)

U.S. Cancer Death Rates Continue to Fall

FDA Approves Nivolumab Dosing Update

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab Dosing Update

Nurse Empowerment

ChemoSafe Program Aims to Strengthen Access to Cancer Treatment in Sub-Saharan Africa

What Is the Role of Interprofessional Teams in a BMT Unit?

Interprofessional Teams

What Is the Role of Interprofessional Teams in a BMT Unit?

Interprofessional Collaborations Improve Cancer Care

Interprofessional Teams

Interprofessional Collaborations Improve Cancer Care

ONS Leaders Named to Biden Cancer Initiative Board and Advisory Committee

ONS Leaders Named to Biden Cancer Initiative Board and Advisory Committee

February 27, 2018

Overview of Radiation Therapy for Cancer

Radiation Therapy

Get an Overview of Radiation Therapy for Cancer

February 27, 2018

FDA Approves Abemaciclib As Initial Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Abemaciclib As Initial Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer

February 26, 2018

Nursing Education on New Drug Approvals

U.S. Food and Drug Administration (FDA)

How One ONS Chapter Is Providing Education on New Drug Approvals

February 20, 2018

The Case of the Cancer Genetics Referral

Clinical Practice

The Case of the Cancer Genetics Referral

February 19, 2018

Prevent and Treat Venous Thromboembolism in Patients With Cancer

Clinical Practice

Prevent and Treat Venous Thromboembolism in Patients With Cancer

February 17, 2018

FDA Approves Durvalumab After Chemoradiation for Unresectable Stage III NSCLC

U.S. Food and Drug Administration (FDA)

FDA Approves Durvalumab After Chemoradiation for Unresectable Stage III NSCLC

February 16, 2018

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Apalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

February 14, 2018

Search the Literature to Critically Appraise Evidence

Evidence-Based Practice

Search the Literature to Critically Appraise Evidence

February 13, 2018

Nursing Interventions Help Reduce Chemotherapy Symptom Burden

Symptom Management

Motivational Interviewing Nursing Interventions Help Reduce Chemotherapy Symptom Burden

February 12, 2018

fda

U.S. Food and Drug Administration (FDA)

FDA Approves Abiraterone Acetate With Prednisone for High-Risk Metastatic CSPC

February 08, 2018

How ONS Is Advocating for Our Patients and Our Profession

How ONS Is Advocating for Our Patients and Our Profession

February 06, 2018

Cognitive Behavioral Therapy Helps Patients With Cancer Manage Insomnia

Symptom Management

How Can Cognitive Behavioral Therapy Help Patients With Cancer Manage Insomnia?

February 01, 2018

Sleep-Wake Disturbances in Patients With Cancer

Symptom Management

Sleep-Wake Disturbances in Patients With Cancer

February 01, 2018

fda

U.S. Food and Drug Administration (FDA)

FDA Approves Lutetium Lu 177 Dotatate for Treatment of GEP-NETS

January 26, 2018

Immunotherapy Without Immune Cells

Immunotherapy Without Immune Cells May Be on the Horizon

January 24, 2018

Back to Top ▲